Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind crossover study of sibutramine on energy intake and expenditure in obese subjects
2005-002080-88Phase 4Completed
- Sponsor
- Aintree University Hospital NHS Foundation Trust
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sibutramine in obesity (3 arms), sponsored by Aintree University Hospital NHS Foundation Trust. Primary endpoints: Effect of placebo and sibutramine 10 mg and 15 mg on food intake and Effect of sibutramine on energy expenditure. Started Aug 2005; status: completed.
02
Drugs
sibutramine
03
Conditions
obesity
Beyond the preview
Go deeper on 2005-002080-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002080-88.